For instance, Huang Y et al. showed that the inhibition of nuclear factor erythroid 2-related factor 2 (Nrf2) increases CRC chemotherapy sensitivity by promoting ferroptosis and apoptosis [14]. This evidence concerns the gene NFE2L2 and colorectal carcinoma.